http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006527242-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
filingDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006527242-A
titleOfInvention Cyclic hydroxylamine as a neuroactive compound
abstract [Chemical 1] X represents O or CH 2 ; R 3 and R 4 each independently represent hydrogen or C 1-6 alkyl; p represents 0 or 1; and R represents formulas (II), (III ) And (IV) represents a 5- or 6-membered saturated or unsaturated ring; or R represents: R 1 and R 2 together represent an oxo group, or R 1 and R 2 Each represents hydrogen, methoxy or ethoxy, or R 1 and R 2 are connected together via the intervening carbon atom via the 2-position and optionally one or more methyl or ethyl groups Represents an unsaturated ring substituted with a 5- or 6-membered oxo selected from (V) and (VI) forming a retained 1,3-dioxolane or 1,3-dioxane ring; ) Compound: or a salt thereof, anxiety and Suitable for the treatment of depression.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016520112-A
priorityDate 2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05255220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002506459-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466233205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466233190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466233231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466183817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466233208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466233206

Total number of triples: 30.